SMSPHARMA2023-10-012023-12-31 SMSPHARMA2023-10-012023-12-31 SMSPHARMA2023-10-012023-12-31in-bse-fin:OneOperatingExpenses01Member SMSPHARMA2023-10-012023-12-31in-bse-fin:OneOperatingExpenses02Member SMSPHARMA2023-10-012023-12-31in-bse-fin:FourOperatingExpenses01Member SMSPHARMA2023-10-012023-12-31in-bse-fin:FourOperatingExpenses02Member SMSPHARMA2023-12-31 iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532815 SMSPHARMA NOTLISTED SMS Pharmaceuticals Limited Equity 2023-04-01 2024-03-31 2024-02-08 2024-02-02 INR Lakhs Third quarter 15:30:00 18:40:00 2024-02-08 2024-02-08 Not applicable Single segment Bulk Drugs 2023-10-01 2023-12-31 Unaudited Standalone 1614822000.00 14908000.00 1629730000.00 1325989000.00 0.00 -412213000.00 140162000.00 59527000.00 80085000.00 272101000.00 1465651000.00 164079000.00 0.00 164079000.00 39978000.00 2373000.00 42351000.00 0.00 121728000.00 0.00 0.00 0.00 0.00 121728000.00 -667000.00 121061000.00 121061000.00 0.00 84652000.00 1 1.44 1.44 0.00 0.00 1.44 1.44 1 The above un-audited standalone financial results for the quarter ended December 31, 2023 have been reviewed by the Audit Committee on February 07, 2024 and approved by the Board of Directors at their meeting held on February 08, 2024. The Statutory Auditors of the Company have carried out a Limited Review on Standalone Financial Results for the quarter ended December 31, 2023 and expressed an unmodified conclusion thereon. 2 These Standalone Financial Results of the Company have been prepared in accordance with the Indian Accounting Standards prescribed under Section 133 of the Companies Act, 2013 ( the Act ) read with relevant rules issued thereunder ('IND AS') and other accounting principles generally accepted in India and guidelines issued by the Securities and Exchange Board of India ( SEBI ). (Listing Obligations and Disclosure Requirements) Regulations, 2015. 3 The Company is engaged in the manufacturing of Active Pharmaceutical Ingredients and their intermediates and the same constitutes a single reportable business segment as per Ind AS108. 4 Figures for the previous period have been reclassified/ regrouped wherever necessary to confirm to current period's classification. Single segment 2023-04-01 2023-12-31 Unaudited Standalone 4634651000.00 28140000.00 4662791000.00 3274396000.00 0.00 -642249000.00 412160000.00 178476000.00 235994000.00 756768000.00 4215545000.00 447246000.00 0.00 447246000.00 104978000.00 7238000.00 112216000.00 0.00 335030000.00 0.00 0.00 0.00 0.00 335030000.00 -1847000.00 333183000.00 333183000.00 0.00 84652000.00 1 3.96 3.96 0.00 0.00 3.96 3.96 Manufactuing Expenses 195195000.00 Other Expenses 76906000.00 Manufactuing Expenses 515894000.00 Other Expenses 240874000.00 667000.00 1847000.00 0.00 0.00